Guyer Charles Greg

EVP, Chief Technical OfficerBIOMARIN PHARMACEUTICAL INC (BMRN) · full profile →Form 4 · filed Nov 14, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$350K
Net Open-Market Flow
-$350K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 12, 2024Sell(S)5K$66.37$350K69K
Oct 31, 2024Grant(A)55$56.01$3K74K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001048477-24-000154) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.